KARACHI: Prime Minister Shehbaz Sharif on Tuesday honoured leading exporters from various industries at a ceremony attended by a select group of chairpersons and chief executives of major companies, says a press release.
At an elegant ceremony, the PM gave award to Getz Pharma Chairman Khalid Mehmood. Getz Pharma was one of the 30 companies recognized for being the highest exporter in pharmaceuticals in 2025. The company has been part of State Bank’s list of top 50 exporters, currently 33rd overall, and is the largest taxpayer, employer and investor in the pharmaceutical industry.
It has been receiving the FPCCI award for being the top exporter in the pharmaceutical sector for the last 19 consecutive years and is the only company in Pakistan to have this honour. Founded in 1995, Getz Pharma’s success in global markets is rooted in an unwavering commitment to quality and compliance, reflected in accreditations from leading regulatory agencies of regulated markets, including the World Health Organization-Geneva, Eurasian Economic Union (EAEU) and PIC/S. Every pack exported to more than 40 countries is manufactured at Getz Pharma’s internationally accredited and approved facilities at Karachi.
Over the past 15 years, Getz Pharma has invested nearly Rs50 billion in cutting edge manufacturing plants, quality management systems, and advanced technologies. It is the first company in Pakistan that set up a Biotechnology Manufacturing Facility in 2007, where it manufactured the first Human Insulin (Insuget) and Insulin Analogues (Basagin) in Pakistan.
The company remained the only manufacturer of insulins in Pakistan for over 17 years. In 2024 the company met another major milestone by expanding its Biotechnology facility where it is producing GIP and GLP-1 Receptor Agonist (RA) biosimilars which is a monumental innovation to treat obesity and metabolic diseases.
In its new biotechnology facility, the company is producing and marketing, Sem-P (injectable Semaglutide) in easy-to-use pens and vials, Sem-O (oral Semaglutide tablet), and Tirzee (Tirzepatide) in a single-dose auto-injector pen for unmatched patient convenience and efficacy. All of Getz Pharma’s GLP-1 and GIP RA biosimilars are produced, bio-assayed and are peptide mapped for bio similarity, and are independently verified by accredited international laboratories.
